ストックスクリーナーアプリを入手
11.62
9.64%
-1.24
前日終値:
$12.86
開ける：
$12.7
24時間の取引高:
7.18M
Relative Volume:
4.36
時価総額：
$1.15B
収益：
-
当期純損益:
$-44.84M
株価収益率:
-24.72
EPS:
-0.47
ネットキャッシュフロー:
$-44.23M
1週間 パフォーマンス:
-13.93%
1か月 パフォーマンス:
-34.54%
6か月 パフォーマンス:
+13.92%
1年 パフォーマンス:
-10.48%
1日の値動き範囲:
$10.98
$12.70
1週間の範囲:
$10.98
$14.00
52週間の値動き範囲:
$10.01
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
名前
Ars Pharmaceuticals Inc
セクター
電話
858-771-9307
住所
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
SPRY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
11.62 | 1.27B | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-02-10 | 開始されました | Oppenheimer | Outperform |
| 2024-08-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | 繰り返されました | Leerink Partners | Outperform |
| 2024-07-25 | 開始されました | Raymond James | Outperform |
| 2024-03-05 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 開始されました | Wedbush | Outperform |
| 2023-01-03 | 開始されました | William Blair | Outperform |
| 2022-12-13 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Ars Pharmaceuticals Inc (SPRY) 最新ニュース
Real time pattern detection on ARS Pharmaceuticals Inc. stockIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
Is ARS Pharmaceuticals Inc. forming a bottoming baseLayoff News & Daily Growth Stock Investment Tips - Newser
ARS Pharmaceuticals Inc. recovery potential after sell offEntry Point & Low Risk Entry Point Tips - Newser
Quantitative breakdown of ARS Pharmaceuticals Inc. recent moveTreasury Yields & Fast Entry Momentum Trade Alerts - Newser
Technical analysis overview for ARS Pharmaceuticals Inc. stockJuly 2025 Levels & Daily Oversold Bounce Ideas - Newser
How to interpret RSI for ARS Pharmaceuticals Inc. stockBull Run & Technical Entry and Exit Alerts - Newser
Price momentum metrics for ARS Pharmaceuticals Inc. explained2025 Support & Resistance & High Yield Stock Recommendations - Newser
What machine learning models say about ARS Pharmaceuticals Inc.New Guidance & Breakout Confirmation Trade Signals - Newser
What machine learning models say about ARS Pharmaceuticals IncJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Custom watchlist performance reports with ARS Pharmaceuticals Inc.Fed Meeting & Daily Growth Stock Tips - Newser
What MACD and RSI say about ARS Pharmaceuticals Inc.Long Setup & Expert Verified Movement Alerts - Newser
Can ARS Pharmaceuticals Inc. rally from current levelsAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
Custom watchlist performance reports with ARS Pharmaceuticals IncProfit Target & Daily Technical Forecast Reports - Newser
Risk vs reward if holding onto ARS Pharmaceuticals Inc.Oil Prices & Community Verified Trade Signals - Newser
Using data models to predict ARS Pharmaceuticals Inc. stock movementJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Comparing ARS Pharmaceuticals Inc. in custom built stock radarsCEO Change & Verified Short-Term Plans - Newser
What recovery options are there for ARS Pharmaceuticals Inc.2025 Sector Review & Fast Moving Stock Watchlists - Newser
ARS Pharmaceuticals Faces Wider Loss in Q2, Stirring Market Concerns - StocksToTrade
Trading Bots Trigger Alerts on ARS Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
ARS Pharmaceuticals Down 9% as Lupin Files Generic Neffy Application - AInvest
Ranking ARS Pharmaceuticals Inc. among high performing stocks via toolsMarket Activity Summary & AI Driven Stock Price Forecasts - Newser
What the charts say about ARS Pharmaceuticals Inc. today2025 Biggest Moves & AI Driven Stock Reports - Newser
How high can ARS Pharmaceuticals Inc. stock go2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
Applying Elliott Wave Theory to ARS Pharmaceuticals Inc.2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Detecting price anomalies in ARS Pharmaceuticals Inc. with AIJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
ARS Pharma drops 9% as Lupin files application for generic neffy - MSN
ARS Pharmaceuticals Faces Financial Struggles as Q2 Loss Exceeds Estimates - StocksToTrade
ARS Pharmaceuticals Plunges 8.7%—What Legal Storm Could Sink Neffy's Future? - AInvest
Published on: 2025-08-29 02:08:09 - Newser
Ars Pharmaceuticals Inc (SPRY) 財務データ
収益
当期純利益
現金流量
EPS
0.96%
1.09%
大文字化:
|
ボリューム (24 時間):